Fitzgerald/KLF7 antibody/10R-8678/50 ul
商品编号：
10R-8678-50ul
品牌：
fitzgerald-fii
市场价：
¥3900.00
美元价：
2925.00
产品分类：
功能性抗体
公司分类：
Functional_antibody
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
OVERVIEW:
| Synonyms | Monoclonal KLF7 antibody, Anti KLF7 antibody, Kruppel-like factor 7 antibody, UKLF antibody |
|---|---|
| Applications | ELISA, WB |
| Immunogen | KLF7 antibody was raised in Mouse using recombinant human KLF7 (1-302aa) purified from E. coli as the immunogen |
SPECIFICATIONS:
| Host | Mouse |
|---|---|
| Clone | AT3G3 |
| Isotype | IgG1 kappa |
| Method of Purification | KLF7 antibody was purified by protein A affinity chromatography |
| Form & Buffer | Supplied in liquid form in Phosphate-Buffered Saline (pH 7.4) containing 10% Glycerol, 0.02% Sodium Azide |
| Concentration | 1 mg/ml |
STORAGE & SAFETY:
| Storage | Can be stored at 4 deg C. For long term storage, aliquot and store at -20 deg C. Avoid repeated freezing and thawing cycles. |
|---|
Usage Assay Information:
| Usage Recommendations | ELISA: 1:1000, WB: 1:1000 |
|---|
GENERAL INFORMATION:
| Biological Significance | KLK7 is a member of the Kruppel-like transcriptional regulator family. Members in this family regulate cell proliferation, differentiation, survival and the development of nervous systems.and contain three C2H2 zinc fingers at the C-terminus that mediate binding to GC-rich sites. KLF7 is binds specifically to an Ikaros core binding element that is crucial for in vivo NTRK1/TrkA enhancer function. This protein may contribute to the progression of type 2 diabetes by inhibiting insulin expression and secretion in pancreatic beta-cells and by deregulating adipocytokine secretion in adipocytes. A pseudogene of this gene is located on the long arm of chromosome 3. Alternative splicing results in multiple transcript variants. |
|---|
品牌介绍
美国Fitzgerald 公司是一家国际性知名抗体研发生产企业。Fitzgerald公司为全球试剂诊断公司与研究机构提供专业的抗体、纯化抗原以及工业诊断用大包装免疫原料。公司产品多达5000种，能够满足您对于最前沿科学研究的需求。产品涉及：单克隆抗体／抗原生育类、传染病类、TORCH系列、肿瘤标记物、心脏标记物、神经科学类、病毒类等等。
品牌分类
重组蛋白
联络我们
